Evidence map›Paper›PMID 27369050›Full record

ArticleTransgenic research2016

Protection against vascular leak in neprilysin transgenic mice with complex overexpression pattern.

Marilee J Wick, Zoe L Loomis, Julie W Harral, Mysan Le, Carol A Wehling, York E Miller, Edward C Dempsey

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse.Journal of visualized experiments : JoVE · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Marilee J WickCardiovascular Pulmonary Research Laboratory, University of Colorado Denver, RC-2, Box B-133, 12700 E. 19th Ave., Aurora, CO, 80045, USA. Marilee.wick@ucdenver.edu.
Zoe L LoomisCardiovascular Pulmonary Research Laboratory, University of Colorado Denver, RC-2, Box B-133, 12700 E. 19th Ave., Aurora, CO, 80045, USA.
Julie W HarralCardiovascular Pulmonary Research Laboratory, University of Colorado Denver, RC-2, Box B-133, 12700 E. 19th Ave., Aurora, CO, 80045, USA.
Mysan LeDenver VA Medical Center, Denver, CO, 80220, USA.
Carol A WehlingDenver VA Medical Center, Denver, CO, 80220, USA.
York E MillerDivision of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO, 80045, USA.
Edward C DempseyCardiovascular Pulmonary Research Laboratory, University of Colorado Denver, RC-2, Box B-133, 12700 E. 19th Ave., Aurora, CO, 80045, USA.
University of Colorado Denver · USDenver VA Medical Center · US

Funding

Selected Peptidases and Pulmonary Vascular Remodeling in Chronic Obstructive PulmR03HL095439 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DEMPSEY, EDWARD CHARLES · 2008 to 2009
$154k
NHLBI NIH HHS R03 HL095439
6 · The paper itself

Abstract

Neprilysin (NEP) is a cell surface metallopeptidase found in many tissues. Based mostly on pharmacological manipulations, NEP has been thought to protect blood vessels from plasma extravasation. We have suggested that NEP may protect against pulmonary vascular injury. However, these prior studies did not utilize mice which overexpress NEP. The aims of the present investigation were to develop and characterize doubly transgenic (DT) mice that overexpress NEP universally and conditionally, and to investigate the protective effect that overexpressed NEP may have against plasma extravasation in the vasculature. The duodenum, which is often used to assess vascular permeability, and in which the NEP protein was overexpressed in our DT mice two-fold, was selected as our experimental preparation. We found that substance P-induced plasma extravasation was decreased substantially (3.5-fold) in the duodenums of our doxycycline-treated DT mice, giving independent evidence of NEP's protective effects against plasma extravasation. Transgenic lung NEP protein was not stably expressed in the DT mice, so we were not able to test the effect of NEP overexpression in the lung. Although initially overexpressed nearly nine-fold at that site, pulmonary NEP protein overexpression eventually dissipated. Surprisingly, at a time when there was no lung transgenic NEP protein overexpression, lung NEP mRNA expression was still increased 23-fold, indicating that the expression defect probably is not transcriptional. These studies help to characterize our complex transgenic model of NEP overexpression and further demonstrate NEP's protective effects against plasma extravasation.

Indexed as

AnimalsBlood VesselsDoxycyclineDuodenumGene Expression RegulationLungMiceMice, TransgenicNeprilysinSubstance PDoxycyclineNeprilysinSubstance PDuodenumEvans blueNeprilysinRosa26 promoterTransgenic mouseVascular leak

Identifiers

PMID27369050
OpenAlexW2460825231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.